Russia Lab Death Sharpens Debate Over Biotechnology Controls

Posted 10/6/26

 An unexplained death at a Russian high-containment biological research facility is putting renewed attention on a problem that U.S. export-control officials have been confronting for several years: biotechnology is advancing faster than the regulatory architecture intended to keep dangerous biological capabilities from proliferating.

This item is available in full to subscribers.

Please log in to continue

Log in